Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ECMO Braile Biomédica® in COVID-19 Patients Post-market Clinical Trial to Verify the Performance of the ECMO System

NCT06086405 is registered in ClinicalTrials.gov with Braile Biomedica Ind. Com. e Repr. Ltda. as lead sponsor.

NCT NCT06086405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06086405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ECMO Braile Biomédica® in COVID-19 Patients Post-market Clinical Trial to Verify the Performance of the ECMO System
Lead sponsor
Braile Biomedica Ind. Com. e Repr. Ltda.
Phase
Observational
Overall status
Unknown status
Start date
September 14, 2023
Completion date
March 31, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19